R Griksiene, R Monciunskaite, O Ruksenas - Frontiers in …, 2022 - Elsevier
Progestins are an important component of hormonal contraceptives (HCs) and hormone replacement therapies (HRTs). Despite an increasing number of studies elucidating the …
E Timby, M Balgård, S Nyberg, O Spigset… - …, 2006 - Springer
Rationale The behavioral effects of allopregnanolone (3α-hydroxy-5α-pregnan-20-one) in women are not known. Objective Allopregnanolone, a neuroactive steroid secreted by the …
Souborná učebnice, první svého druhu, zahrnuje všechny obory psychologie, které nezbytně potřebuje znát každý student lékařské fakulty. Publikace je jedinečná propojením …
CI Jarvis, AM Lynch, AK Morin - Annals of Pharmacotherapy, 2008 - journals.sagepub.com
Objective: To evaluate the current nonpharmacologic and pharmacologic treatment options for symptoms of premenstrual syndrome (PMS) and premenstrual dysphoric disorder …
EW Freeman, SJ Sondheimer - Primary care companion to …, 2003 - legacy.psychiatrist.com
Premenstrual dysphoric disorder (PMDD) represents the more severe and disabling end of the spectrum of premenstrual syndrome and occurs in an estimated 2% to 9% of …
U Halbreich, PMS O'Brien, E Eriksson, T Bäckström… - CNS drugs, 2006 - Springer
Current evidence suggests that the accepted treatments for premenstrual syndrome (PMS)/premenstrual dysphoric disorder (PMDD) have similar overall efficacy. While these …
Premenstrual syndrome (PMS) and its derivative Premenstrual Dysphoric Disorder (PMDD) are controversial medical diagnoses. On one hand they are ubiquitous in English-language …
S O'Brien, A Rapkin, L Dennerstein, T Nevatte - Bmj, 2011 - bmj.com
Premenstrual disorders have a substantial social, occupational, academic, and psychological effect on the lives of millions of women (from menarche to menopause) and …
Contradictory findings show both positive and negative effect of progesterone on the premenstrual mood changes in women. Here we present the study investigating this …